Large-scale biorepositories and databases are essential to generate equitable, effective,
and sustainable advances in cancer prevention, early detection, cancer therapy, cancer …

Abstract The Global Cancer Genomics Consortium (GCGC) is an international collaborative
platform that amalgamates cancer biologists, cutting-edge genomics, and high-throughput …

Classical epidemiologic studies have made seminal contributions to identifying the etiology
of most common cancers. Molecular epidemiology was conceived of as an extension of …

PL01-01 Decades of research into genetics and molecular biology of cancer are painting an
increasingly detailed picture of the molecular basis of the disease, confirming that cancer is …

To the Editor: Genomics data are valuable for studying the molecular bases of diseases as
well as developing effective treatments. Advances in high-throughput technologies have …

In the past decade, genomics has fundamentally changed our view of cancer biology,
allowing comprehensive analyses of mutations, copy number alterations, structural variants …

The genomics era has yielded great advances in the understanding of cancer biology. At the
same time, the immense complexity of the cancer genome has been revealed, as well as a …

The Cancer Genome Atlas (TCGA) is a public funded project that aims to catalogue and
discover major cancer-causing genomic alterations to create a comprehensive “atlas” of …

Cancer genomes have been explored from the early 2000s through massive exome
sequencing efforts, leading to the publication of The Cancer Genome Atlas in 2013 …

Cancer is one of the four major non‑communicable diseases (NCD), responsible for~ 14.6%
of all human deaths. Currently, there are> 100 different known types of cancer and> 500 …